Cardiovascular risk associated with HIV therapy

被引:23
作者
Currier, JS [1 ]
机构
[1] Univ Calif Los Angeles, Ctr AIDS Res & Educ, Los Angeles, CA 90095 USA
关键词
D O I
10.1097/00126334-200209011-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S16 / S23
页数:8
相关论文
共 24 条
[11]   Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors [J].
Maggi, P ;
Serio, G ;
Epifani, G ;
Fiorentino, G ;
Saracino, A ;
Fico, C ;
Perilli, F ;
Lillo, A ;
Ferraro, S ;
Gargiulo, M ;
Chirianni, A ;
Angarano, G ;
Regina, G ;
Pastore, G .
AIDS, 2000, 14 (16) :F123-F128
[12]  
MARTINEZ E, 2002, 9 C RETR OPP INF SEA
[13]  
MARYKRAUSE M, 2001, 8 C RETR OPP INF CHI
[14]  
MILLER J, 2001, 8 C RETR OPP INF CHI
[15]  
MOE A, 2000, 13 INT AIDS C DURB S
[16]   Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy [J].
Moyle, GJ ;
Lloyd, M ;
Reynolds, B ;
Baldwin, C ;
Mandalia, S ;
Gazzard, BG .
AIDS, 2001, 15 (12) :1503-1508
[17]   ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results [J].
Murphy, RL ;
Brun, S ;
Hicks, C ;
Eron, JT ;
Gulick, R ;
King, M ;
White, AC ;
Benson, C ;
Thompson, M ;
Kessler, HA ;
Hammer, S ;
Bertz, R ;
Hsu, A ;
Japour, A ;
Sun, E .
AIDS, 2001, 15 (01) :F1-F9
[18]   Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors [J].
Périard, D ;
Telenti, A ;
Sudre, P ;
Cheseaux, JJ ;
Halfon, P ;
Reymond, MJ ;
Marcovina, SM ;
Glauser, MP ;
Nicod, P ;
Darioli, R ;
Mooser, V .
CIRCULATION, 1999, 100 (07) :700-705
[19]  
POWDERLY WG, 2000, 40 INT C ANT AG CHEM
[20]   Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects [J].
Purnell, JQ ;
Zambon, A ;
Knopp, RH ;
Pizzuti, DJ ;
Achari, R ;
Leonard, JM ;
Locke, C ;
Brunzell, JD .
AIDS, 2000, 14 (01) :51-57